The University recently received a generous donation pledge from Mr. Francis Law Sau Fai, Executive Director of Toyo Mall Limited, in support of a project entitled “Research and Development of Innovative Combination Drugs in Traditional Chinese Medicine". The project is conducted by the Institute for Advancing Translational Medicine in Bone & Joint Diseases under the School of Chinese Medicine. The research focuses on new drug discovery for the treatment of rheumatoid arthritis, osteoporosis and bone tumor.

To acknowledge the donor’s generosity, the Institute was named the “Law Sau Fai Institute for Advancing Translational Medicine in Bone & Joint Diseases” (TMBJ). A recognition ceremony officiated by Mr. Francis Law, his family and Professor Roland T. Chin, President and Vice-Chancellor, was held on 13 April 2017. After the ceremony, Mr. Law and his guests visited the TMBJ, research laboratories and Dr. & Mrs. Hung Hin Shiu Museum of Chinese Medicine. They also received an update on the latest developments of the School.

Guests and HKBU representatives attending the ceremony and visit included Mr. Law’s sister Mrs. Mona Ma; his son Mr. Dominic Law; Dr. Kennedy Y.H. Wong, BBS, JP, Managing Partner of Philip K H Wong, Kennedy Y H Wong & Co.; Mr. David Fong, BBS, JP, Managing Director of Hip Shing Hong Group; Dr. Jacinto Tong, Vice Chairman and Chief Executive Officer of Gale Well Group Limited; Dr. Kim Mak, BBS, JP, President of Caritas Institute of Higher Education and Caritas Bianchi College of Careers; Ms. Maggie Chan, Director of Caritas Social Work Services; Ms. Anita Fung, Senior Tax Manager, Toyo Mall Limited; Professor Rick Wong, Vice-President (Research & Development); Professor Bian Zhaoxiang, Associate Vice-President (Traditional Chinese Medicine); Mr. Yeung Chee Kong, Associate Vice-President (Engagement); Professor Lyu Aiping, Dean of Chinese Medicine and Director of TMBJ; Professor Zhang Ge, Associate Director of TMBJ; and Mrs. Lily Chan, Director of University Advancement and Secretary-General of the Hong Kong Baptist University Foundation.

Established in 2012, TMBJ aims at providing multidisciplinary scientists from Faculty of Science and School of Chinese Medicine a synergistic collaboration platform which efficiently and effectively translate basic scientific findings into knowledge that benefits patients with bone and joint diseases, which is often described as an effort to carry scientific knowledge "from bench to bedside". To this end, the TMBJ functions as a unit to integrate academic resource and industrial network to facilitate development of innovative bioinformatics approach to drug discovery, novel biological reagents, unique therapeutic agents, advanced bio-imaging modalities and new biomaterials for diagnosis, prevention and treatment toward Phase-I clinical trials and commercialisation in bone & joint diseases.